The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway

标题
The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway
作者
关键词
SGLT2 inhibitor, NAFLD, Autophagy, IL-17/IL-23 axis, Inflammatory responses
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 94, Issue -, Pages 107492
出版商
Elsevier BV
发表日期
2021-02-26
DOI
10.1016/j.intimp.2021.107492

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started